Zobrazeno 1 - 10
of 1 068
pro vyhledávání: '"Stephen, Lam"'
Autor:
Choong-kun Lee, Changhoon Yoo, Jung Yong Hong, Se Jun Park, Jin Won Kim, David Wai Meng Tai, Hyeyeong Kim, Krittiya Korphaisarn, Suebpong Tanasanvimon, San-Chi Chen, Ju Won Kim, Ilhwan Kim, Moonho Kim, Joan Choo, Sang-Bo Oh, Ching-Tso Chen, Woo Kyun Bae, Hongsik Kim, Seok Jae Huh, Chia-Jui Yen, Sejung Park, Dong Ki Lee, Landon Long Chan, Beodeul Kang, Minsu Kang, Raghav Sundar, Hye Jin Choi, Stephen Lam Chan, Hong Jae Chon, Myung-Ah Lee
Publikováno v:
Liver Cancer, Pp 1-15 (2024)
Introduction: Atezolizumab plus bevacizumab is a commonly used first-line regimen for advanced hepatocellular carcinoma (HCC) treatment owing to its superior outcomes compared to sorafenib. However, optimal subsequent treatment options for patients w
Externí odkaz:
https://doaj.org/article/48cd992dee674cbb8551afa29b350663
Autor:
Julia R. Naso, Stephen Yip, Curtis Hughesman, Barb Melosky, Tanner Dowhy, Melissa K. McConechy, John C. English, Penelope M. A. Brasher, James Choi, Kyle Grant, John Yee, Stephen Lam, Anna McGuire
Publikováno v:
Current Oncology, Vol 31, Iss 7, Pp 4052-4062 (2024)
Appropriate management requires timely and accurate confirmation of non-small cell lung cancer (NSCLC) recurrence in patients who have had curative-intent surgical resection. We assessed the association between circulating tumor DNA (ctDNA) identifie
Externí odkaz:
https://doaj.org/article/b18337e3aa12439f9926c642c63041ac
Autor:
Jan Sebek, Steven Goh, Warren L. Beard, David S. Biller, David S. Hodgson, Margaret A. Highland, Abbe Smith, Nicholas Hemphill, Kun-Chang Yu, Renelle A. Myers, Stephen Lam, Henky Wibowo, Punit Prakash
Publikováno v:
Biomedicine Hub, Vol 9, Iss 1, Pp 108-117 (2024)
Introduction: Percutaneous microwave ablation (MWA) is clinically accepted for the treatment of lung tumors and oligometastatic disease. Bronchoscopic MWA is under development and evaluation in the clinical setting. We previously reported on the deve
Externí odkaz:
https://doaj.org/article/09d83ca9cdbb4a6b9196462396418957
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background An increasing proportion of lung adenocarcinoma (LUAD) occurs in patients even after they have stopped smoking. Here, we aimed to determine whether tobacco smoking induced changes across LUADs from patients who formerly smoked cor
Externí odkaz:
https://doaj.org/article/d1cc08a9a5524077944370da23039055
Autor:
Xiaoyu Liu, Man Liu, Haoran Wu, Wenshu Tang, Weiqin Yang, Thomas T.H. Chan, Lingyun Zhang, Shufen Chen, Zhewen Xiong, Jianxin Liang, Willis Wai-Yiu Si-Tou, Ting Shu, Jingqing Li, Jianquan Cao, Chengpeng Zhong, Hanyong Sun, Tsz Tung Kwong, Howard H.W. Leung, John Wong, Paul Bo-San Lai, Ka-Fai To, Tingxiu Xiang, Joseph Jao-Yiu Sung, Stephen Lam Chan, Jingying Zhou, Alfred Sze-Lok Cheng
Publikováno v:
JHEP Reports, Vol 6, Iss 7, Pp 101087- (2024)
Background & Aims: Recent studies demonstrated the importance of fibrosis in promoting an immunosuppressive liver microenvironment and thereby aggressive hepatocellular carcinoma (HCC) growth and resistance to immune checkpoint blockade (ICB), partic
Externí odkaz:
https://doaj.org/article/548a0fa4c9c849b8b8cb170ca38dbeaf
Autor:
Xinan Wang, Ziwei Zhang, Yi Ding, Tony Chen, Lorelei Mucci, Demetrios Albanes, Maria Teresa Landi, Neil E. Caporaso, Stephen Lam, Adonina Tardon, Chu Chen, Stig E. Bojesen, Mattias Johansson, Angela Risch, Heike Bickeböller, H-Erich Wichmann, Gadi Rennert, Susanne Arnold, Paul Brennan, James D. McKay, John K. Field, Sanjay S. Shete, Loic Le Marchand, Geoffrey Liu, Angeline S. Andrew, Lambertus A. Kiemeney, Shan Zienolddiny-Narui, Annelie Behndig, Mikael Johansson, Angie Cox, Philip Lazarus, Matthew B. Schabath, Melinda C. Aldrich, Rayjean J. Hung, Christopher I. Amos, Xihong Lin, David C. Christiani
Publikováno v:
Genome Medicine, Vol 16, Iss 1, Pp 1-11 (2024)
Abstract Background Although polygenic risk score (PRS) has emerged as a promising tool for predicting cancer risk from genome-wide association studies (GWAS), the individual-level accuracy of lung cancer PRS and the extent to which its impact on sub
Externí odkaz:
https://doaj.org/article/f2a83eace6cb48e6be31892d21e98222
Autor:
Alpamys Issanov, Atul Aravindakshan, Lorri Puil, Martin C. Tammemägi, Stephen Lam, Trevor J. B. Dummer
Publikováno v:
Diagnostic and Prognostic Research, Vol 8, Iss 1, Pp 1-8 (2024)
Abstract Background Lung cancer is one of the most commonly diagnosed cancers and the leading cause of cancer-related death worldwide. Although smoking is the primary cause of the cancer, lung cancer is also commonly diagnosed in people who have neve
Externí odkaz:
https://doaj.org/article/d0362efdf1464d63a6c832fdb6662ae9
Autor:
Asha Bonney, John Brodersen, Volkert Siersma, Katharine See, Henry M. Marshall, Daniel Steinfort, Louis Irving, Linda Lin, Jiashi Li, Siyuan Pang, Paul Fogarty, Fraser Brims, Annette McWilliams, Emily Stone, Stephen Lam, Kwun M. Fong, Renee Manser
Publikováno v:
Health and Quality of Life Outcomes, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background Evaluation of psychosocial consequences of lung cancer screening with LDCT in high-risk populations has generally been performed using generic psychometric instruments. Such generic instruments have low coverage and low power to d
Externí odkaz:
https://doaj.org/article/33b02c1d149048b6a655767cabc7f500
Autor:
Liu, Xiaoyu, Liu, Man, Wu, Haoran, Tang, Wenshu, Yang, Weiqin, Chan, Thomas T.H., Zhang, Lingyun, Chen, Shufen, Xiong, Zhewen, Liang, Jianxin, Wai-Yiu Si-Tou, Willis, Shu, Ting, Li, Jingqing, Cao, Jianquan, Zhong, Chengpeng, Sun, Hanyong, Kwong, Tsz Tung, Leung, Howard H.W., Wong, John, Bo-San Lai, Paul, To, Ka-Fai, Xiang, Tingxiu, Jao-Yiu Sung, Joseph, Chan, Stephen Lam, Zhou, Jingying, Sze-Lok Cheng, Alfred
Publikováno v:
In JHEP Reports July 2024 6(7)
Publikováno v:
Journal of Liver Cancer, Vol 23, Iss 2, Pp 262-271 (2023)
Hepatocellular carcinoma (HCC) frequently presents as advanced stage with poor prognosis and high mortality. Systemic treatment is the treatment of choice for advanced disease. In 2007, the first multi-kinase inhibitor (MKI) sorafenib was approved an
Externí odkaz:
https://doaj.org/article/1c49ebdb3a6c4f39aed29a0a858c4aeb